RxDoctor Payments Data

Kyle Vaughn, PA

Medical · Norfolk, VANPI 1841739141

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,216, 5.2 times the $423 reported in 2021. Among medical clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,694in general payments, 2019–2025

Across 292 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$832
  • Amgen$787
  • AstraZeneca$741
  • Bayer$641
  • Otsuka America Pharmaceutical, Inc.$567
  • Ardelyx, Inc.$467
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$6,63399%
  • Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,694 in reported general payments places this provider in the 90th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Medicare billing

Part B allowed, 2024
$42,901
Medicare patients
257
Services billed
492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sevelamer Carbonate64$16,185
Calcium Acetate48$2,783
Bumetanide73$2,529
Midodrine Hcl14$1,917
Nifedipine ErNifedipine43$781
Potassium Chloride50$706
Hydralazine Hcl45$686
Carvedilol103$609
Calcitriol27$512
Furosemide75$472
Losartan Potassium74$450
Amlodipine Besylate88$445
Allopurinol27$396
Metoprolol Succinate13$253
Minoxidil16$248

Paid to pharmacies, not to this prescriber.

Other medical in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →